2Terezakis SA, Lee KS, Ghossein RA, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience [ J ]. Int J Radiat Oncol Biol Phys.2009,73 ( 3 ) : 795-801. DOI: 10. 1016/j.ijrobp.2008.05.012.
3Keum KC, Suh YG, Koom WS, et al. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea [J]. Int J Radiat Oncol Biol Phys. 2006, 65 (2) : 474--480. DOI : 10.1016/j.ijrobp. 2005.12.010.
3David GP, David HJ, Christopher GA, et al. American society of clinical oncology treatment of unresected non-small-cell lung cancer guideline : update 2003, J Clin Oncol,2003,22:330-353.
4Liebmann J,Cook JA,Fisher J,et al. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int J Radiat Oncol Biol Phys, 1994,29:559-564.
5Rijn JV,Berg JV,Meijer OWM. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel, Int J Radiat Oncol Biol Phys, 1995, 33:635 -639.
6Tishler RB, Schiff PB, Geard CR, et al. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys, 1992,22:613-617.
7Zanelli GD,Quaia M, Robieux I, et al. Paclitaxel as a radiosensitiser: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations. Euro J Cancer, 1997,33:486- 492.
8Chen Y,Kishan P,Keng PC, et al. Phase Ⅰ / Ⅱ clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin Cancer Res,2003 ,9 :969-975.
9Zanelli GD,Quaia M, Robieux I, et al. Paclitaxel as a radiosensiriser: a proposed schedule of administration based on In Vitro data and pharmacokinetic calculations. Eur J Cancer, 1997,33 : 486- 492.
10Monzo M,Rosell R,Sanchez JJ,et al. Paclitaxel resistance in nonsmall cell lung cancer associated with beta-tubulin gene mutations. J Clin Oncol, 1999,17 : 1786-1793.
